Guggenheim Capital LLC Takeda Pharmaceutical CO LTD Transaction History

Guggenheim Capital LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$13.12 - $15.03 $26,331 - $30,165	-2,007 Reduced 9.69%	18,715 $263,000
Q1 2022 May 16, 2022	SELL	$13.54 - $15.35 $1,150 - $1,304	-85 Reduced 0.41%	20,722 $297,000
Q4 2021 Feb 14, 2022	SELL	$13.17 - $16.4 $29,290 - $36,473	-2,224 Reduced 9.66%	20,807 $284,000
Q3 2021 Nov 15, 2021	BUY	$16.3 - $17.26 $34,735 - $36,781	2,131 Added 10.2%	23,031 $377,000
Q2 2021 Aug 13, 2021	BUY	$16.55 - $18.64 $345,895 - $389,576	20,900 New	20,900 $352,000

Q4 2020 Feb 16, 2021	SELL	$15.39 - $18.97 $162,118 - $199,829	-10,534 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$17.1 - $19.19 $21,015 - $23,584	-1,229 Reduced 10.45%	10,534 $188,000
Q2 2020 Aug 14, 2020	SELL	$14.59 - $19.5 $56,113 - $74,997	-3,846 Reduced 24.64%	11,763 $211,000
Q1 2020 Jun 02, 2020	BUY	$13.02 - $20.31 $27,693 - $43,199	2,127 Added 15.78%	15,609 $237,000
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $25,252 - $31,161	1,496 Added 12.48%	13,482 $266,000
Q3 2019 Nov 14, 2019	BUY	$16.15 - $17.99 $193,573 - $215,628	11,986 New	11,986 $206,000

340

76M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Guggenheim Capital LLC with notifications on news.